Effects of subclinical prostatitis on benign prostatic hyperlasia

Korean Journal of Urology

Volumn 50, Issue 2, 2009, Pages 154-158

  Kim, Hyun Woo ^a   Kim, Sang Hoon ^a   Kim, Sae Woong ^a   Jung, Kyu In ^a   Min, Ki Ouk ^a   Cho, Su Yeon ^a  

^a The Catholic University of Korea College of Medicine   (South Korea)

Author keywords

Benign prostatic hyperplasia; Prostatitis; Symptoms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANALYTICAL PARAMETERS; ARTICLE; CHRONIC INFLAMMATION; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; HUMAN; HUMAN TISSUE; INFLAMMATORY CELL; INTERNATIONAL PROSTATE SYMPTOM SCORE; LOWER URINARY TRACT SYMPTOM; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MICTURITION DISORDER; ORGAN SIZE; PROSTATE HYPERTROPHY; PROSTATE SPECIFIC ANTIGEN DENSITY; PROSTATITIS; QUALITY OF LIFE; STORAGE SYMPTOM; SYMPTOM; TRANSURETHRAL RESECTION; URINE FLOW RATE;

EID: 61849158165     PISSN: 20056737     EISSN: 20056745     Source Type: Journal    
DOI: 10.4111/kju.2009.50.2.154     Document Type: Article

References (29)

1. Chung TG, Chung J, Lee MS, Ahn H. Prevalence of benign prostatic hyperplasia in Jeong-up area: community-based study. Korean J Urol 1999;40:52-8
2. Woo YN. Prostatitis. Korean J Urol 1994;35:575-85
3. Nickel JC, Downey J, Hunter D, Clark J. Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health chronic prostatitis symptom index. J Urol 2001;165:842-5
4. Nickel JC. Prostatic inflammation in benign prostatic hyperplasia-the third component? Can J Urol 1994;1:1-4
5. Nickel JC. The overlapping lower urinary tract symptoms of benign prostatic hyperplasia and prostatitis. Curr Opin Urol 2006;16:5-10
6. Kohnen PW, Drach GW. Patterns of inflammation in prostatic hyperplasia: a histologic and bacteriologic study. J Urol 1979; 121:755-60
7. Irani J, Levillain P, Goujon JM, Bon D, Dore B, Aubert J. Inflammation in benign prostatic hyperplasia: correlation with prostatic specific antigen value. J Urol 1997;157:1301-3
8. Chute CG, Panser LA, Girman CJ, Oesterling JE, Guess HA, Jacobsen SJ, et al. The prevalence of prostatism: a population-based survey of urinary symptoms. J Urol 1993;150:85-9
9. Caine M. The present role of alpha-adrenergic blockers in the treatment of benign prostatic hypertrophy. J Urol 1986;136:1-4
10. Shapiro E, Lepor H. Pathophysiology of clinical benign prostatic hyperplasia. Urol Clin North Am 1995;22:285-90
11. McConnell JD. Benign prostatic hyperplasia. Hormonal treatment. Urol Clin North Am 1995;22:387-400
12. Lepor H. Alpha blockade for the treatment of benign prostatic hyperplasia. Urol Clin North Am 1995;22:375-86
13. Emberton M, Elhilali M, Matzkin H, Harving N, van Moorselaar J, Hartung R, et al. Symptom deterioration during treatment and history of AUR are the strongest predictors for AUR and BPH-related surgery in men with LUTS treated with alfuzosin 10mg once daily. Urology 2005;66:316-22
14. Stoner E. The clinical development of a 5 α-reductase inhibitor, finasteride. J Steroid Biochem Mol Biol 1990;37:375-8
15. Kaplan SA, Te AE, Pressler LB, Olsson CA. Transition zone index as a method of assessing benign prostatic hyperplasia: correlation with symptoms, urine flow and detrusor pressure. J Urol 1995;154:1764-9
16. Lee SO, Cho IR, Lee KC, Kim HS. Elevation of serum prostate specific antigen in subclinical prostatitis: the role of pathology of inflammation. Korean J Urol 2006;47:31-6
17. Mishra VC, Allen DJ, Nicolaou C, Sharif H, Hudd C, Karim OM, et al. Does intraprostatic inflammation have a role in the pathogenesis and progression of benign prostatic hyperplasia? BJU Int 2007;100:327-31
18. Kohnen PW, Drach GW. Patterns of inflammation in prostatic hyperplasia: a histologic and bacteriologic study. J Urol 1979;121:755-60
19. Nickel JC, Roehrborn CG, O'Leary MP, Bostwick DG, Somerville MC, Rittmaster RS. The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial. Eur Urol 2008;54:1379-84
20. Lee SY, Park YY. Clinical characteristics of the associated histopathological findings in benign prostatic hyperplasia. Korean J Urol 1991;32:915-20
21. Nickel JC, Downey J, Young I, Boag S. Asymptomatic inflammation and/or infection in benign prostatic hyperplasia. BJU Int 1999;84:976-81
22. Kramer G, Marberger M. Could inflammation be a key component in the progression of benign prostatic hyperplasia? Curr Opin Urol 2006;16:25-9
23. St Sauver JL, Jacobson DJ, McGree ME, Lieber MM, Jacobsen SJ. Protective association between nonsteroidal atiinflammatory drug use and measures of benign prostatic hyperplasia. Am J Epidemiol 2006;164:760-8
24. Kramer G, Steiner GE, Handisurya A, Stix U, Haitel A, Knerer B, et al. Increased expression of lymphocyte-derived cytokines in benign hyperplastic prostate tissue, identification of the producing cell types, and effect of differentially expressed cytokines on stromal cell proliferation. Prostate 2002;52:43-58
25. Handisurya A, Steiner GE, Stix U, Ecker RC, Pfaffeneder-Mantai S, Langer D, et al. Differential expression of interleukin-15, a pro-inflammatory cytokine and T-cell growth factor, and its receptor in human prostate. Prostate 2001;49:251-62
26. Roehrborn CG, Kaplan SA, Noble WD, Slawin KM, McVary KT, Kusek JW. The impact of acute or chronic inflammation in baseline biopsy on the risk of clinical progression of BPH. Results from the MTOPS study. J Urol 2005;173(Suppl): abstract 1277
27. Okada K, Kojima M, Naya Y, Kamoi K, Yokoyama K, Takamatsu T, et al. Correlation of histological inflammation in needle biopsy specimens with serum prostate-specific antigen levels in men with negative biopsy for prostate cancer. Urology 2000;55:892-8
28. Moser PL, Brunner A, Horninger W, Bartsch G, Mikuz G. Correlation between inflammatory cells (T and B lymphocytes, macrophages) in prostate biopsies and elevated PSA levels in a PSA screening population. Urology 2002;59:68-72
29. Ozden C, Ozdal OL, Guzel O, Han O, Seckin S, Memis A. The correlation between serum prostate specific antigen levels and asymptomatic inflammatory prostatitis. Int Urol Nephrol 2007;39:859-63